Skip to main content

One2Treat launches groundbreaking treatment-decision approach to clinical research and market access analysis

One2Treat launches groundbreaking treatment-decision approach to clinical research and market access analysis One2Treat reflects patient priorities in a single comprehensive treatment evaluation, reducing trial sample size and accelerating patient access to new treatments Brussels, March 26th, 2024 – One2Treat, a new innovative start-up offering cutting edge digital health solutions, launches…

Read More

PDC*line Pharma and partners receive €8.1M from Walloon region and Wallonia health cluster BioWin for personalized therapeutic vaccine project

PDC*line Pharma and partners receive €8.1M from Walloon region and Wallonia health cluster BioWin for personalized therapeutic vaccine project PDC*neo+ project aims to develop personalized therapeutic vaccine based on neoantigens for colorectal cancer Collaborative effort between biotechnology companies, PDC*line Pharma and OncoDNA, technology company salamanderU and universities UCLouvain–IREC/MIRO and ULB-BCTL…

Read More

Walloon Government launches innovation partnership with €81 million budget over three years, dedicated to ATMPs, in collaboration with BioWin and the Public service of Wallonia

Walloon Government launches innovation partnership with €81 million budget over three years, dedicated to ATMPs, in collaboration with BioWin and the Public service of Wallonia Innovation partnership specific to Advanced Therapy Medicinal Products (ATMPs) brings together 26 partners for 12 work packages Suarlée, Namur, Belgium, January 17, 2024 – In...
Read More

Bioxodes closes €12 million in Series A funding round

Bioxodes closes €12 million in  Series A funding round Funding will enable Bioxodes to continue clinical development of drug candidate for patients with intracerebral hemorrhage Recruitment of first patient for phase IIa proof-of-concept clinical trial due before end of Q4, 2023 Gosselies, Belgium, November 21, 2023 – Bioxodes SA, a biopharmaceutical company specializing…

Read More